Global Pharmaceutical Contract Sales Outsourcing (CSO) Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report ID: GIR2204210003 | Category: Service & Software | Pages: 103 | Format: PDF | Published Date: May 13,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Pharmaceutical Contract Sales Outsourcing (CSO) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Pharmaceutical Contract Sales Outsourcing (CSO) market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during forecast period 2022-2028. Hospital accounting for  % of the Pharmaceutical Contract Sales Outsourcing (CSO) global market in 2021, is projected to value USD  million by 2028, growing at a  % CAGR in next six years. While Cardiovascular Disorders segment is altered to a  % CAGR between 2022 and 2028.
Global key companies of Pharmaceutical Contract Sales Outsourcing (CSO) include Ashfield (UDG Healthcare plc), InVentiv Health, Inc. (Syneos Health), IQVIA, Granard Pharmaceutical Sales & Marketing, and Vanguard Pharma, Inc., etc. In terms of revenue, the global top four players hold a share over  % in 2021.
Market segmentation
Pharmaceutical Contract Sales Outsourcing (CSO) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Cardiovascular Disorders
    Oncology
    Metabolic Disorders
    Neurology
    Others
Market segment by Application, can be divided into
    Hospital
    Clinic
    Others
Market segment by players, this report covers
    Ashfield (UDG Healthcare plc)
    InVentiv Health, Inc. (Syneos Health)
    IQVIA
    Granard Pharmaceutical Sales & Marketing
    Vanguard Pharma, Inc.
    GTS Solution
    EVERSANA
    MaBiCo
    QFR Solutions
    Pharmaforce Ireland Ltd.
    Sales Focus, Inc.
    Amplity Health
    PharmaLex GmbH
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Pharmaceutical Contract Sales Outsourcing (CSO) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Pharmaceutical Contract Sales Outsourcing (CSO), with revenue, gross margin and global market share of Pharmaceutical Contract Sales Outsourcing (CSO) from 2019 to 2022.
Chapter 3, the Pharmaceutical Contract Sales Outsourcing (CSO) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Pharmaceutical Contract Sales Outsourcing (CSO) market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Pharmaceutical Contract Sales Outsourcing (CSO) research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Product Overview and Scope of Pharmaceutical Contract Sales Outsourcing (CSO)
    1.2 Classification of Pharmaceutical Contract Sales Outsourcing (CSO) by Type
        1.2.1 Overview: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share by Type in 2021
        1.2.3 Cardiovascular Disorders
        1.2.4 Oncology
        1.2.5 Metabolic Disorders
        1.2.6 Neurology
        1.2.7 Others
    1.3 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market by Application
        1.3.1 Overview: Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size & Forecast
    1.5 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Forecast by Region
        1.5.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Region, (2017-2022)
        1.5.3 North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Prospect (2017-2028)
        1.5.4 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Prospect (2017-2028)
        1.5.6 South America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Pharmaceutical Contract Sales Outsourcing (CSO) Market Drivers
        1.6.2 Pharmaceutical Contract Sales Outsourcing (CSO) Market Restraints
        1.6.3 Pharmaceutical Contract Sales Outsourcing (CSO) Trends Analysis
2 Company Profiles
    2.1 Ashfield (UDG Healthcare plc)
        2.1.1 Ashfield (UDG Healthcare plc) Details
        2.1.2 Ashfield (UDG Healthcare plc) Major Business
        2.1.3 Ashfield (UDG Healthcare plc) Pharmaceutical Contract Sales Outsourcing (CSO) Product and Solutions
        2.1.4 Ashfield (UDG Healthcare plc) Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Ashfield (UDG Healthcare plc) Recent Developments and Future Plans
    2.2 InVentiv Health, Inc. (Syneos Health)
        2.2.1 InVentiv Health, Inc. (Syneos Health) Details
        2.2.2 InVentiv Health, Inc. (Syneos Health) Major Business
        2.2.3 InVentiv Health, Inc. (Syneos Health) Pharmaceutical Contract Sales Outsourcing (CSO) Product and Solutions
        2.2.4 InVentiv Health, Inc. (Syneos Health) Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 InVentiv Health, Inc. (Syneos Health) Recent Developments and Future Plans
    2.3 IQVIA
        2.3.1 IQVIA Details
        2.3.2 IQVIA Major Business
        2.3.3 IQVIA Pharmaceutical Contract Sales Outsourcing (CSO) Product and Solutions
        2.3.4 IQVIA Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 IQVIA Recent Developments and Future Plans
    2.4 Granard Pharmaceutical Sales & Marketing
        2.4.1 Granard Pharmaceutical Sales & Marketing Details
        2.4.2 Granard Pharmaceutical Sales & Marketing Major Business
        2.4.3 Granard Pharmaceutical Sales & Marketing Pharmaceutical Contract Sales Outsourcing (CSO) Product and Solutions
        2.4.4 Granard Pharmaceutical Sales & Marketing Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Granard Pharmaceutical Sales & Marketing Recent Developments and Future Plans
    2.5 Vanguard Pharma, Inc.
        2.5.1 Vanguard Pharma, Inc. Details
        2.5.2 Vanguard Pharma, Inc. Major Business
        2.5.3 Vanguard Pharma, Inc. Pharmaceutical Contract Sales Outsourcing (CSO) Product and Solutions
        2.5.4 Vanguard Pharma, Inc. Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Vanguard Pharma, Inc. Recent Developments and Future Plans
    2.6 GTS Solution
        2.6.1 GTS Solution Details
        2.6.2 GTS Solution Major Business
        2.6.3 GTS Solution Pharmaceutical Contract Sales Outsourcing (CSO) Product and Solutions
        2.6.4 GTS Solution Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 GTS Solution Recent Developments and Future Plans
    2.7 EVERSANA
        2.7.1 EVERSANA Details
        2.7.2 EVERSANA Major Business
        2.7.3 EVERSANA Pharmaceutical Contract Sales Outsourcing (CSO) Product and Solutions
        2.7.4 EVERSANA Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 EVERSANA Recent Developments and Future Plans
    2.8 MaBiCo
        2.8.1 MaBiCo Details
        2.8.2 MaBiCo Major Business
        2.8.3 MaBiCo Pharmaceutical Contract Sales Outsourcing (CSO) Product and Solutions
        2.8.4 MaBiCo Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 MaBiCo Recent Developments and Future Plans
    2.9 QFR Solutions
        2.9.1 QFR Solutions Details
        2.9.2 QFR Solutions Major Business
        2.9.3 QFR Solutions Pharmaceutical Contract Sales Outsourcing (CSO) Product and Solutions
        2.9.4 QFR Solutions Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 QFR Solutions Recent Developments and Future Plans
    2.10 Pharmaforce Ireland Ltd. 
        2.10.1 Pharmaforce Ireland Ltd. Details
        2.10.2 Pharmaforce Ireland Ltd. Major Business
        2.10.3 Pharmaforce Ireland Ltd. Pharmaceutical Contract Sales Outsourcing (CSO) Product and Solutions
        2.10.4 Pharmaforce Ireland Ltd. Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Pharmaforce Ireland Ltd. Recent Developments and Future Plans
    2.11 Sales Focus, Inc.
        2.11.1 Sales Focus, Inc. Details
        2.11.2 Sales Focus, Inc. Major Business
        2.11.3 Sales Focus, Inc. Pharmaceutical Contract Sales Outsourcing (CSO) Product and Solutions
        2.11.4 Sales Focus, Inc. Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Sales Focus, Inc. Recent Developments and Future Plans
    2.12 Amplity Health
        2.12.1 Amplity Health Details
        2.12.2 Amplity Health Major Business
        2.12.3 Amplity Health Pharmaceutical Contract Sales Outsourcing (CSO) Product and Solutions
        2.12.4 Amplity Health Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 Amplity Health Recent Developments and Future Plans
    2.13 PharmaLex GmbH
        2.13.1 PharmaLex GmbH Details
        2.13.2 PharmaLex GmbH Major Business
        2.13.3 PharmaLex GmbH Pharmaceutical Contract Sales Outsourcing (CSO) Product and Solutions
        2.13.4 PharmaLex GmbH Pharmaceutical Contract Sales Outsourcing (CSO) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 PharmaLex GmbH Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Pharmaceutical Contract Sales Outsourcing (CSO) Players Market Share in 2021
        3.2.2 Top 10 Pharmaceutical Contract Sales Outsourcing (CSO) Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Pharmaceutical Contract Sales Outsourcing (CSO) Players Head Office, Products and Services Provided
    3.4 Pharmaceutical Contract Sales Outsourcing (CSO) Mergers & Acquisitions
    3.5 Pharmaceutical Contract Sales Outsourcing (CSO) New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Revenue and Market Share by Type (2017-2022)
    4.2 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
    5.1 Global Pharmaceutical Contract Sales Outsourcing (CSO) Revenue Market Share by Application (2017-2022)
    5.2 Global Pharmaceutical Contract Sales Outsourcing (CSO) Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
    6.1 North America Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Type (2017-2028)
    6.2 North America Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Application (2017-2028)
    6.3 North America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country
        6.3.1 North America Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Country (2017-2028)
        6.3.2 United States Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Forecast (2017-2028)
        6.3.3 Canada Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Forecast (2017-2028)
        6.3.4 Mexico Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
    7.1 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Type (2017-2028)
    7.2 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Application (2017-2028)
    7.3 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country
        7.3.1 Europe Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Country (2017-2028)
        7.3.2 Germany Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Forecast (2017-2028)
        7.3.3 France Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Forecast (2017-2028)
        7.3.5 Russia Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Forecast (2017-2028)
        7.3.6 Italy Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Type (2017-2028)
    8.2 Asia-Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Application (2017-2028)
    8.3 Asia-Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Region
        8.3.1 Asia-Pacific Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Region (2017-2028)
        8.3.2 China Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Forecast (2017-2028)
        8.3.3 Japan Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Forecast (2017-2028)
        8.3.4 South Korea Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Forecast (2017-2028)
        8.3.5 India Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Forecast (2017-2028)
        8.3.7 Australia Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
    9.1 South America Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Type (2017-2028)
    9.2 South America Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Application (2017-2028)
    9.3 South America Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country
        9.3.1 South America Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Country (2017-2028)
        9.3.2 Brazil Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Forecast (2017-2028)
        9.3.3 Argentina Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Type (2017-2028)
    10.2 Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Application (2017-2028)
    10.3 Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Market Size by Country
        10.3.1 Middle East & Africa Pharmaceutical Contract Sales Outsourcing (CSO) Revenue by Country (2017-2028)
        10.3.2 Turkey Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Forecast (2017-2028)
        10.3.4 UAE Pharmaceutical Contract Sales Outsourcing (CSO) Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Pharmaceutical Contract Sales Outsourcing (CSO) Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?